SCHEMBL26066092

SCHEMBL26066092

FC(F)(F)c1ccc(SN2CC3(C2)CN(C2CCOCC2)C3)c(C2CC2)n1

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 1/20 0.33
▸ TGFBR1 P36897 1/20 0.33
▸ PDE9A O76083 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26065534 0.87 PDE9A (0.31) PDE9A
SCHEMBL26066088 0.86 IRAK4 (0.33) PDE9A
SCHEMBL26066096 0.85 — —
SCHEMBL26066066 0.85 CHRM4 (0.36) TGFBR1
SCHEMBL26066125 0.83 — —
SCHEMBL26066127 0.83 KCNH2 (0.32) PDE9A
SCHEMBL26065529 0.81 TLR9 (0.34) —
SCHEMBL26066080 0.80 HTR2A (0.32) —
SCHEMBL26066145 0.79 — —
SCHEMBL26065407 0.79 LRRK2 (0.31) LRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023164063-A1 EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF BIOGEN MA INC. (US) 2023-08-31 — — WO disclosed
Send feedback